Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom

From All Marijuana Stocks | Ad

With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.

Get All the Details on #1Interstate Cannabis

ZYME Insider Trading (Zymeworks)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.14%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,963,651.02

Zymeworks Insider Trading History Chart

Zymeworks Share Price & Price History

^$36.25

▼ -1.93 (-5.06%)

As of 06/18/2021 01:00 AM ET

Days: 30 | 90 | 365

Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom

From All Marijuana Stocks | Ad

Get All the Details on #1Interstate Cannabis

Zymeworks Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/13/2021	James Priour	Insider	Sell	950	$27.93	$26,533.50	2,953
3/15/2021	Kathryn O'driscoll	Insider	Sell	786	$34.72	$27,289.92	5,003
3/10/2021	Ali Tehrani	CEO	Sell	4,392	$34.95	$153,500.40	264,717
3/10/2021	Kathryn O'driscoll	Insider	Sell	568	$34.95	$19,851.60	6,357
3/10/2021	Neil A Klompas	CFO	Sell	1,425	$34.95	$49,803.75	11,896
12/9/2020	Neil A Klompas	CFO	Sell	25,000	$53.25	$1,331,250.00	17,502
12/7/2020	Ali Tehrani	CEO	Sell	850	$56.16	$47,736.00	257,009
12/4/2020	Diana Hausman	Insider	Sell	6,032	$55.12	$332,483.84	6,568
12/2/2020	Diana Hausman	Insider	Sell	701	$55.01	$38,562.01	7,840
11/2/2020	Ali Tehrani	CEO	Sell	3,500	$39.04	$136,640.00	257,009
9/14/2020	Diana Hausman	Insider	Sell	40,000	$45.00	$1,800,000.00	13,718
4/3/2020	Ali Tehrani	CEO	Buy	575	$33.39	$19,199.25	256,009
1/27/2020	Troy Cox	Director	Buy	7,500	$46.50	$348,750.00	7,500
5/6/2019	David Kai Yuen Poon	Insider	Sell	800	$19.20	$15,360.00
5/6/2019	Neil A Klompas	CFO	Sell	8,308	$19.23	$159,762.84
3/29/2019	Ali Tehrani	CEO	Sell	3,000	$16.24	$48,720.00
1/31/2019	Eli & Co Lilly	Major Shareholder	Sell	250,000	$16.00	$4,000,000.00
11/6/2018	Eli & Co Lilly	Major Shareholder	Sell	700,000	$14.00	$9,800,000.00
9/24/2018	Eli & Co Lilly	Major Shareholder	Sell	2,027	$16.36	$33,161.72
9/17/2018	Eli & Co Lilly	Major Shareholder	Sell	15,874	$14.58	$231,442.92
9/13/2018	Eli & Co Lilly	Major Shareholder	Sell	30,959	$14.49	$448,595.91
9/11/2018	Eli & Co Lilly	Major Shareholder	Sell	15,777	$14.75	$232,710.75
8/30/2018	Eli & Co Lilly	Major Shareholder	Sell	5,752	$14.31	$82,311.12
8/13/2018	Eli & Co Lilly	Major Shareholder	Sell	6,429	$14.32	$92,063.28
8/2/2018	Eli & Co Lilly	Major Shareholder	Sell	19,400	$13.31	$258,214.00

SEC Filings (Institutional Ownership Changes) for Zymeworks (NYSE:ZYME)

76.11% of Zymeworks stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Zymeworks Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Squarepoint Ops LLC	9,991	$0.32M	0.0%	N/A	0.022%
5/18/2021	Millennium Management LLC	94,736	$2.99M	0.0%	-57.1%	0.205%
5/18/2021	Voloridge Investment Management LLC	19,577	$0.62M	0.0%	+249.8%	0.042%
5/18/2021	First Light Asset Management LLC	117,848	$3.72M	0.2%	-40.4%	0.255%
5/18/2021	Point72 Asset Management L.P.	158,600	$5.01M	0.0%	-80.5%	0.344%
5/18/2021	D. E. Shaw & Co. Inc.	19,342	$0.61M	0.0%	-71.7%	0.042%
5/18/2021	Morgan Stanley	1,742,574	$55.03M	0.0%	+12.9%	3.774%
5/18/2021	Redmile Group LLC	985,700	$31.13M	0.4%	-9.4%	2.135%
5/18/2021	Alyeska Investment Group L.P.	287,265	$9.07M	0.1%	+44.9%	0.622%
5/18/2021	Cormorant Asset Management LP	2,000,000	$63.16M	1.4%	+66.7%	4.332%
5/18/2021	Cubist Systematic Strategies LLC	39,330	$1.24M	0.0%	+11.2%	0.085%
5/18/2021	Twinbeech Capital LP	9,450	$0.30M	0.0%	N/A	0.020%
5/18/2021	FORA Capital LLC	1,337	$42K	0.0%	-36.6%	0.003%
5/18/2021	Holocene Advisors LP	604,650	$19.10M	0.1%	+33.5%	1.310%
5/17/2021	Schonfeld Strategic Advisors LLC	16,817	$0.53M	0.0%	N/A	0.036%
5/17/2021	PDT Partners LLC	81,318	$2.57M	0.2%	N/A	0.176%
5/17/2021	Perceptive Advisors LLC	4,330,868	$136.77M	1.7%	+0.7%	9.380%
5/17/2021	Royal Bank of Canada	20,142	$0.64M	0.0%	-48.4%	0.044%
5/17/2021	Armistice Capital LLC	1,650,000	$52.11M	1.2%	+266.7%	3.574%
5/17/2021	Price T Rowe Associates Inc. MD	1,185,797	$37.45M	0.0%	-0.4%	2.568%
5/17/2021	Scion Asset Management LLC	281,018	$8.88M	0.7%	N/A	0.609%
5/17/2021	Thrivent Financial for Lutherans	314,817	$9.94M	0.0%	+28.6%	0.682%
5/17/2021	Goldman Sachs Group Inc.	55,943	$1.77M	0.0%	-53.1%	0.121%
5/14/2021	Arrowstreet Capital Limited Partnership	90,111	$2.85M	0.0%	+27.8%	0.195%
5/14/2021	Weiss Multi Strategy Advisers LLC	16,465	$0.52M	0.0%	-18.1%	0.036%
5/14/2021	Dimensional Fund Advisors LP	20,502	$0.65M	0.0%	-10.6%	0.044%
5/14/2021	TD Asset Management Inc.	32,362	$1.02M	0.0%	+20.3%	0.070%
5/14/2021	UBS Asset Management Americas Inc.	1,029,712	$32.52M	0.0%	+59.7%	2.230%
5/14/2021	Dynamic Technology Lab Private Ltd	7,738	$0.24M	0.0%	N/A	0.017%
5/14/2021	Credit Suisse AG	2,291,489	$72.37M	0.0%	+25.1%	4.963%
5/14/2021	Quantbot Technologies LP	4,028	$0.13M	0.0%	N/A	0.009%
5/13/2021	Guggenheim Capital LLC	20,633	$0.65M	0.0%	+91.2%	0.045%
5/13/2021	SG Americas Securities LLC	191,491	$6.05M	0.0%	+970.0%	0.415%
5/13/2021	Barclays PLC	17,025	$0.54M	0.0%	+1,022.3%	0.037%
5/13/2021	Renaissance Technologies LLC	139,100	$4.39M	0.0%	+938.1%	0.301%
5/13/2021	Bank of New York Mellon Corp	28,996	$0.92M	0.0%	-1.8%	0.063%
5/13/2021	Citigroup Inc.	3,840	$0.12M	0.0%	-21.1%	0.008%
5/13/2021	Bank of Montreal Can	15,573	$0.48M	0.0%	+40.7%	0.034%
5/13/2021	Platinum Investment Management Ltd.	102,944	$3.25M	0.1%	+96.7%	0.223%
5/12/2021	Northern Trust Corp	40,568	$1.28M	0.0%	-18.1%	0.088%
5/12/2021	Ensign Peak Advisors Inc	26,892	$0.85M	0.0%	+51.9%	0.058%
5/12/2021	JPMorgan Chase & Co.	24,059	$0.76M	0.0%	-112.5%	0.052%
5/12/2021	UBS Group AG	9,108	$0.29M	0.0%	-47.4%	0.020%
5/10/2021	Russell Investments Group Ltd.	2,705	$85K	0.0%	-68.9%	0.006%
5/10/2021	Moody Aldrich Partners LLC	33,228	$1.05M	0.2%	+1.2%	0.072%
5/7/2021	BlackRock Inc.	385,469	$12.17M	0.0%	-1.8%	0.835%
5/7/2021	Alps Advisors Inc.	83,127	$2.63M	0.0%	+0.8%	0.180%
5/7/2021	Swiss National Bank	78,600	$2.48M	0.0%	+1.6%	0.170%
5/7/2021	North Growth Management Ltd.	58,000	$1.84M	0.3%	+18.4%	0.126%
5/4/2021	Victory Capital Management Inc.	39,160	$1.24M	0.0%	-4.3%	0.085%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	4,097	$0.13M	0.0%	-20.6%	0.009%
5/3/2021	Raymond James Trust N.A.	10,107	$0.32M	0.0%	+21.7%	0.022%
4/30/2021	Exane Derivatives	5,288	$0.17M	0.0%	+60.2%	0.011%
4/29/2021	Handelsbanken Fonder AB	81,700	$2.58M	0.0%	+1,119.4%	0.177%
4/28/2021	US Bancorp DE	6,465	$0.20M	0.0%	-4.7%	0.014%
4/27/2021	State of New Jersey Common Pension Fund D	58,641	$1.85M	0.0%	+24.3%	0.127%
4/21/2021	Taylor Wealth Management Partners	67,505	$2.13M	0.8%	-1.5%	0.146%
3/12/2021	DekaBank Deutsche Girozentrale	6,700	$0.31M	0.0%	-52.1%	0.015%
3/8/2021	Dimensional Fund Advisors LP	22,938	$1.08M	0.0%	+86.9%	0.050%
3/2/2021	Norges Bank	117,255	$5.54M	0.0%	N/A	0.254%
3/1/2021	UBS Asset Management Americas Inc.	644,960	$30.48M	0.0%	+0.6%	1.398%
2/25/2021	Dimensional Fund Advisors LP	22,938	$1.08M	0.0%	+86.9%	0.050%
2/24/2021	Virtu Financial LLC	4,640	$0.22M	0.0%	N/A	0.010%
2/24/2021	Alyeska Investment Group L.P.	198,213	$9.37M	0.1%	-46.6%	0.433%
2/17/2021	Voloridge Investment Management LLC	5,597	$0.27M	0.0%	N/A	0.012%
2/16/2021	Orbimed Advisors LLC	317,002	$14.98M	0.1%	-7.1%	0.692%
2/16/2021	Walleye Trading LLC	5,906	$0.28M	0.0%	N/A	0.013%
2/16/2021	Silverarc Capital Management LLC	30,834	$1.46M	0.8%	N/A	0.067%
2/16/2021	HighVista Strategies LLC	14,608	$0.69M	0.4%	-10.4%	0.032%
2/16/2021	Glenmede Trust Co. NA	4,395	$0.21M	0.0%	+10.2%	0.010%
2/16/2021	Alyeska Investment Group L.P.	198,213	$9.37M	0.1%	-46.6%	0.433%
2/16/2021	Armistice Capital LLC	450,000	$21.27M	0.7%	-37.2%	0.975%
2/16/2021	Morgan Stanley	1,543,645	$72.95M	0.0%	+292.1%	3.368%
2/16/2021	Lone Pine Capital LLC	976,735	$46.16M	0.2%	N/A	2.131%
2/16/2021	Nuveen Asset Management LLC	43,152	$2.04M	0.0%	+162.8%	0.094%
2/16/2021	Guggenheim Capital LLC	10,793	$0.51M	0.0%	N/A	0.024%
2/16/2021	Price T Rowe Associates Inc. MD	1,190,859	$56.28M	0.0%	+6.4%	2.598%
2/16/2021	Avidity Partners Management LP	578,100	$27.32M	0.9%	+136.2%	1.261%
2/16/2021	ExodusPoint Capital Management LP	14,992	$0.71M	0.0%	N/A	0.033%
2/12/2021	Raymond James Financial Services Advisors Inc.	64,427	$3.05M	0.0%	-1.5%	0.141%
2/12/2021	Credit Suisse AG	1,831,561	$86.56M	0.0%	+6.6%	3.997%
2/12/2021	Virtus ETF Advisers LLC	5,726	$0.27M	0.1%	-36.5%	0.012%
2/11/2021	Trexquant Investment LP	5,686	$0.27M	0.0%	N/A	0.012%
2/11/2021	Northern Trust Corp	49,549	$2.34M	0.0%	-4.9%	0.108%
2/11/2021	Handelsbanken Fonder AB	6,700	$0.32M	0.0%	N/A	0.015%
2/11/2021	Artal Group S.A.	350,000	$16.54M	0.4%	N/A	0.764%
2/11/2021	Steward Partners Investment Advisory LLC	1,398	$66K	0.0%	-69.0%	0.003%
2/10/2021	Renaissance Technologies LLC	13,400	$0.63M	0.0%	-93.1%	0.029%
2/9/2021	Wells Fargo & Company MN	457,830	$21.64M	0.0%	-3.7%	0.999%
2/9/2021	Bessemer Group Inc.	750	$35K	0.0%	-25.0%	0.002%
2/9/2021	Bank of New York Mellon Corp	29,526	$1.40M	0.0%	-1.2%	0.064%
2/9/2021	CI Investments Inc.	27,200	$1.29M	0.0%	+7.1%	0.059%
2/8/2021	Vident Investment Advisory LLC	31,168	$1.47M	0.1%	-14.3%	0.068%
2/8/2021	Marathon Capital Management	39,385	$1.86M	0.5%	-14.4%	0.086%
2/8/2021	K.J. Harrison & Partners Inc	90,000	$4.25M	0.7%	+125.0%	0.196%
2/8/2021	Russell Investments Group Ltd.	8,700	$0.41M	0.0%	N/A	0.019%
2/5/2021	BlackRock Inc.	392,563	$18.55M	0.0%	+5.6%	0.857%
2/5/2021	SG Americas Securities LLC	17,897	$0.85M	0.0%	-44.0%	0.039%
2/5/2021	US Bancorp DE	6,783	$0.32M	0.0%	+11.3%	0.015%
2/3/2021	Must Asset Management Inc.	4,405	$0.21M	0.2%	N/A	0.010%

Data available starting January 2016

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

Today's Range

Now: $36.25

$35.95

$38.20

50 Day Range

MA: $31.06

$26.50

$38.23

52 Week Range

Now: $36.25

$24.82

$59.03

Volume

1,410,700 shs

Average Volume

501,209 shs

Market Capitalization

$1.67 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Who are the company insiders with the largest holdings of Zymeworks?

Zymeworks' top insider investors include:

Ali Tehrani (CEO)
Neil A Klompas (CFO)
Diana Hausman (Insider)
Troy Cox (Director)
Kathryn O'driscoll (Insider)
James Priour (Insider)

Who are the major institutional investors of Zymeworks?

Zymeworks' top institutional investors include:

Perceptive Advisors LLC — 9.38%
Credit Suisse AG — 4.96%
Cormorant Asset Management LP — 4.33%
Morgan Stanley — 3.77%
Armistice Capital LLC — 3.57%
Price T Rowe Associates Inc. MD — 2.57%

Which major investors are selling Zymeworks stock?

During the last quarter, ZYME stock was sold by these institutional investors:

Point72 Asset Management L.P.
Millennium Management LLC
Redmile Group LLC
First Light Asset Management LLC
Goldman Sachs Group Inc.
D. E. Shaw & Co. Inc.
Royal Bank of Canada
Northern Trust Corp

During the previous year, company insiders that have sold Zymeworks company stock include:

Ali Tehrani (CEO)
Neil A Klompas (CFO)
Diana Hausman (Insider)
Troy Cox (Director)
Kathryn O'driscoll (Insider)

Which major investors are buying Zymeworks stock?

Within the previous quarter, ZYME stock was purchased by institutional investors including:

Armistice Capital LLC
Cormorant Asset Management LP
Credit Suisse AG
UBS Asset Management Americas Inc.
Scion Asset Management LLC
JPMorgan Chase & Co.
Morgan Stanley
SG Americas Securities LLC

During the last year, these company insiders have bought Zymeworks stock:

Ali Tehrani (CEO)
Neil A Klompas (CFO)

Facebook Billionaire Investing in a Shocking New Industry

From Investing Trends | Ad

Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.

And today, you could get in on the ground floor